Diethylhexyl phthalate induces immune dysregulation and is an environmental immune disruptor.

DEHP Environmental immune disruptor Immune system Sepsis Single-cell RNA sequencing

Journal

Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 13 08 2024
revised: 12 10 2024
accepted: 20 10 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: aheadofprint

Résumé

Diethylhexyl phthalate (DEHP) is the most abundant phthalate compound in the environment, and has been linked with multiple human diseases. The immune system is closely associated with the occurrence and progression of various diseases. However, minimal research has addressed the impact of DEHP on the immune system. In this study, single-cell RNA sequencing was performed using spleen tissue of mice to comprehensively determine alterations of the immune system in response to DEHP. The results showed that DEHP exposure reduced the absolute number of peripheral white blood cells (WBCs), including lymphocytes, monocytes, eosinophils, basophils, and neutrophils in mice. In addition, scRNA-seq analyses showed that inflammatory signaling and the expression of heat shock proteins (HSPs) were reduced in all peripheral immune cell populations. Furthermore, we established a mice cecal ligation and puncture (CLP) model, and showed that DEHP exacerbated sepsis-induced immunosuppression and organ damage. These results suggest that DEHP is an environmental immune disruptor that undermines the immune system, exacerbating acute infections and organ damage. Our findings offer a novel perspective on the hazards of DEHP to human health.

Identifiants

pubmed: 39442302
pii: S0304-3894(24)02823-1
doi: 10.1016/j.jhazmat.2024.136244
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136244

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dongli Linghu (D)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Zhenru Zhu (Z)

Pingshan Hospital, Southern Medical University, Shenzhen, Guangdong, PR China; Pingshan District Peoples' Hospital of Shenzhen, Shenzhen, Guangdong, PR China.

Dongyan Zhang (D)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Yongyi Luo (Y)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Jing Ma (J)

Information Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Tao Li (T)

Medical Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Zhichao Sun (Z)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Zheng Xie (Z)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.

Jingyuan Sun (J)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China. Electronic address: 15013050515@163.com.

Chuanhui Cao (C)

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China; Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangzhou, Guangdong, PR China. Electronic address: huichuancao@163.com.

Classifications MeSH